U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 8

1.

DNA copy number gain at 1q23.3 is associated with poor survival in metastatic bladder cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array; Genome variation profiling by genome tiling array
Platforms:
GPL15793 GPL10150
128 Samples
Download data: CEL, TXT
Series
Accession:
GSE39282
ID:
200039282
2.

DNA copy number gain at 1q23.3 is associated with poor survival in metastatic bladder cancer [Agilent]

(Submitter supplied) Metastatic urothelial carcinoma (UC) of the bladder is associated with multiple somatic copy number alterations (SCNAs). We evaluated SCNAs to identify predictors of poor survival in patients with metastatic UC treated with platinum chemotherapy.
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL10150
94 Samples
Download data: BED, PDF, TXT
Series
Accession:
GSE39281
ID:
200039281
3.

DNA copy number gain at 1q23.3 is associated with poor survival in metastatic bladder cancer [Affymetrix]

(Submitter supplied) Metastatic urothelial carcinoma (UC) of the bladder is associated with multiple somatic copy number alterations (SCNAs). We evaluated SCNAs to identify predictors of poor survival in patients with metastatic UC treated with platinum chemotherapy.
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array
Platform:
GPL15793
34 Samples
Download data: BED, CEL, PDF, TXT
Series
Accession:
GSE39280
ID:
200039280
4.

Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer  

(Submitter supplied) Urothelial carcinoma of the bladder is characterized by significant variability in clinical outcomes depending on stage and grade. The addition of molecular information may improve our understanding of such heterogeneity and enhance prognostic prediction. The purpose of this study was to validate and improve published prognostic signatures for high-risk bladder cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array
Dataset:
GDS4456
Platform:
GPL570
93 Samples
Download data: CEL, TXT
Series
Accession:
GSE31684
ID:
200031684
5.
Full record GDS4456

High-risk bladder cancer

Analysis of bladder cancer specimens from a high-risk population of patients who underwent radical cystectomy (Memorial Sloan-Kettering Cancer Center cohort). Results provide insight into the prediction of survival in high-risk urothelial carcinoma of the urinary bladder.
Organism:
Homo sapiens
Type:
Expression profiling by array, transformed count, 2 disease state, 5 specimen sets
Platform:
GPL570
Series:
GSE31684
93 Samples
Download data: CEL
6.

Identification of nine genomic regions of amplification in bladder cancer, correlation with stage, and potential prognositic and therapeutic value

(Submitter supplied) We sought to test the hypothesis that ascertainment of genome-wide copy number alterations in bladder cancer may have value for clinical management. We performed a genome wide analysis of 164 bladder cancer samples and 27 bladder cancer cell lines to identify genetic changes associated with disease characteristics. Multiplex inversion probe (MIP) analysis, a newly developed genomic technique, was used to study 80 bladder cancers to identify mutations and copy number changes. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array
Platform:
GPL13270
80 Samples
Download data: CEL
Series
Accession:
GSE44323
ID:
200044323
7.

Carboxypeptidase of glutamate-like gene as a tumor suppressor in pancreatic cancer cells and a prognostic marker for resected pancreatic cancer patients

(Submitter supplied) Pancreatic cancer is the fourth leading cancer-related death in United States. The clinical relevance of genomic imbalances in pancreatic cancer is uncertain. We performed array-comparative genomic hybridization (aCGH) in 44 resected pancreatic cancer specimens from a Korean cohort. We observed recurrent copy number gains were observed in chromosome 1q, 11q, 18q11.1-11.2, and 20q13.13; and losses in chromosome 2p, 9p, 10q, 14q, 15q, 18q12.2-23, 19q, 20q11.1, 21p, and 22q. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by array
Platform:
GPL4093
44 Samples
Download data: TXT
Series
Accession:
GSE28732
ID:
200028732
8.

Molecular subtype classification of urothelial carcinoma in Lynch syndrome

(Submitter supplied) We aimed to provide a molecular description of Lynch syndrome-associated urothelial cancer in relation to molecular subtypes of sporadic bladder cancer. Whole genome mRNA expression profiles of 41 tumors and immunohistochemical stainings against FGFR3, KRT5, CCNB1, RB1, and CDKN2A (p16) of 37 tumors from Lynch syndrome patients were generated. Pathological data, microsatellite instability, anatomic location, and overall survival data was analyzed and compared with data from sporadic bladder cancer.
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL6244
41 Samples
Download data: CEL
Series
Accession:
GSE104922
ID:
200104922
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=2|qty=2|blobid=MCID_666d82a56e9d376f2347d5dc|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Support Center